Evolution of Biosimilar Medicines on the Romanian Pharmaceutical Market

Authors

  • Emese Sipos University of Medicine, Pharmacy, Sciences and Tehnology „George Emil Palade” of Târgu Mureș, Pharmaceutical Industry and Management Discipline, Gh. Marinescu street no 38, RO-540116, Târgu Mureș, Romania
  • Emőke Rédai University of Medicine, Pharmacy, Sciences and Tehnology „George Emil Palade” of Târgu Mureș, Pharmaceutical Technology and Cosmetology Discipline, Gh. Marinescu street no 38, RO-540116, Târgu Mureș, Romania
  • Ibolya Fülöp University of Medicine, Pharmacy, Sciences and Tehnology „George Emil Palade” of Târgu Mureș, Toxicology and Biopharmacy Discipline, Gh. Marinescu street no 38, RO-540116, Târgu Mureș, Romania

DOI:

https://doi.org/10.33892/aph.2021.91.314-315

Keywords:

Biosimilar, pharmaceutical market, Romania, evolution

Published

2021-11-15

How to Cite

(1)
Sipos, E.; Rédai, E.; Fülöp, I. Evolution of Biosimilar Medicines on the Romanian Pharmaceutical Market. Acta Pharm Hung 2021, 91, 314-315.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License